NCT04544995 2026-01-21Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)GlaxoSmithKlinePhase 1 Terminated47 enrolled 43 charts
NCT02751528 2025-01-13QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerNantBioScience, Inc.Phase 1 Terminated3 enrolled 10 charts